Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA VENUS REMEDIES DISHMAN PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 30.0 15.0 199.5% View Chart
P/BV x 3.3 0.9 353.2% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
VENUS REMEDIES
Mar-23
DISHMAN PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs374379 98.8%   
Low Rs129145 88.9%   
Sales per share (Unadj.) Rs197.0415.5 47.4%  
Earnings per share (Unadj.) Rs21.219.9 106.6%  
Cash flow per share (Unadj.) Rs34.744.0 78.8%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.9344.3 52.2%  
Shares outstanding (eoy) m80.7013.37 603.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.6 202.7%   
Avg P/E ratio x11.913.2 90.1%  
P/CF ratio (eoy) x7.35.9 121.9%  
Price / Book Value ratio x1.40.8 183.9%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3073,501 580.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,355570 938.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,8985,555 286.2%  
Other income Rs m265103 257.1%   
Total revenues Rs m16,1635,658 285.7%   
Gross profit Rs m4,103602 681.6%  
Depreciation Rs m1,091323 337.7%   
Interest Rs m9443 32,122.4%   
Profit before tax Rs m2,334379 615.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624114 548.7%   
Profit after tax Rs m1,710266 643.7%  
Gross profit margin %25.810.8 238.2%  
Effective tax rate %26.730.0 89.2%   
Net profit margin %10.84.8 224.9%  
BALANCE SHEET DATA
Current assets Rs m11,0183,230 341.2%   
Current liabilities Rs m9,517826 1,152.6%   
Net working cap to sales %9.443.3 21.8%  
Current ratio x1.23.9 29.6%  
Inventory Days Days5737 154.4%  
Debtors Days Days3504 0.7%  
Net fixed assets Rs m18,7872,781 675.5%   
Share capital Rs m161134 120.7%   
"Free" reserves Rs m14,3544,470 321.1%   
Net worth Rs m14,5164,603 315.3%   
Long term debt Rs m4,189387 1,083.1%   
Total assets Rs m29,8056,011 495.9%  
Interest coverage x3.5130.0 2.7%   
Debt to equity ratio x0.30.1 343.5%  
Sales to assets ratio x0.50.9 57.7%   
Return on assets %8.94.5 199.3%  
Return on equity %11.85.8 204.1%  
Return on capital %17.57.7 228.8%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m594NA-   
Fx inflow Rs m4,9520-   
Fx outflow Rs m6970-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,786366 760.8%  
From Investments Rs m-1,529-508 300.8%  
From Financial Activity Rs m-941-6 16,566.9%  
Net Cashflow Rs m317-220 -143.6%  

Share Holding

Indian Promoters % 61.4 41.8 147.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 1.6 1,443.4%  
FIIs % 12.0 1.6 752.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 58.2 66.3%  
Shareholders   52,291 19,560 267.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs VENUS REMEDIES Share Price Performance

Period Dishman Pharma VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 2.87% 7.05% 1.18%
1-Month -2.45% -4.10% -0.75%
1-Year 96.38% 103.11% 61.82%
3-Year CAGR 89.34% 4.62% 18.16%
5-Year CAGR 38.20% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.